{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Seki Y"],"funding":["Japan Society for the Promotion of Science"],"pagination":["861"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12462340"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["25(1)"],"pubmed_abstract":["<h4>Background</h4>Additional treatment options for pharmacotherapy-refractive patients with panic disorder are needed. Given the difficulty in accessing professional cognitive behavioral therapy in real-world clinical settings, pharmacotherapy remains the typical treatment in patients with panic disorder. However, some patients with panic disorder remain symptomatic despite pharmacotherapy. In this study, to highlight next-step treatment options for patients with panic disorder, we aimed to assess the efficacy of videoconference-based cognitive behavioral therapy for patients with panic disorder who remained symptomatic despite initial pharmacological treatment. To this end, we evaluated the effectiveness of videoconference-based cognitive behavioral therapy for patients as an adjunct to "],"journal":["BMC psychiatry"],"pubmed_title":["Videoconference-delivered cognitive behavioral therapy in patients with symptomatic panic disorder following primary pharmacotherapy: a randomized, assessor-blinded, controlled trial."],"pmcid":["PMC12462340"],"funding_grant_id":["16K08863"],"pubmed_authors":["Takemura R","Okamoto Y","Nagata S","Ohira I","Shimizu E","Seki Y","Sutoh C","Noguchi R"],"additional_accession":[]},"is_claimable":false,"name":"Videoconference-delivered cognitive behavioral therapy in patients with symptomatic panic disorder following primary pharmacotherapy: a randomized, assessor-blinded, controlled trial.","description":"<h4>Background</h4>Additional treatment options for pharmacotherapy-refractive patients with panic disorder are needed. Given the difficulty in accessing professional cognitive behavioral therapy in real-world clinical settings, pharmacotherapy remains the typical treatment in patients with panic disorder. However, some patients with panic disorder remain symptomatic despite pharmacotherapy. In this study, to highlight next-step treatment options for patients with panic disorder, we aimed to assess the efficacy of videoconference-based cognitive behavioral therapy for patients with panic disorder who remained symptomatic despite initial pharmacological treatment. To this end, we evaluated the effectiveness of videoconference-based cognitive behavioral therapy for patients as an adjunct to ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-06-03T20:16:38.369Z","creation":"2026-05-30T03:07:08.633Z"},"accession":"S-EPMC12462340","cross_references":{"pubmed":["40993573"],"doi":["10.1186/s12888-025-07320-2"]}}